NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum

By September 13, 2022

EMERYVILLE, Calif. (September 13, 2022)NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Virtual Life Sciences Investor Forum on Thursday, September 15, 2022 at 1:00 p.m. Eastern time (10:00 a.m. Pacific Time). Management will be holding investor one-on-one meetings on September 16 and September 19-20. Investors can register for the conference to view the presentation and request a meeting here.

About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova® is the most prescribed antimicrobial lid and lash spray and DERMAdoctor® is a premium skincare brand offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors.

Socialize and Stay Informed on NovaBays Progress
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website

Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email

DERMAdoctor Purchasing Information
For DERMAdoctor purchasing information:
Please call 877-337-6237 or email

NovaBay Contact
Justin Hall
Chief Executive Officer and General Counsel

Investor Contact
LHA Investor Relations
Jody Cain